Clinical Trials Directory

Trials / Completed

CompletedNCT06871072

Telerehabilitation for Multiple Sclerosis

Telerehabilitation for Multiple Sclerosis: Artificial Intelligence vs. Conventional Approaches in Strength Training. A Sin-gle-Blinded Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
58 (actual)
Sponsor
University of Cadiz · Academic / Other
Sex
All
Age
35 Years – 60 Years
Healthy volunteers
Accepted

Summary

Multiple sclerosis (MS) is a neurodegenerative disease affecting the central nervous system and is a leading cause of disability in young adults. It often produces strength deficits. Exercise has been shown to improve strength, mobility, and quality of life while reducing fatigue. Telerehabilitation offers a convenient, accessible alternative for MS patients. This study explores the use of an AI-powered application for prescribing and monitoring strength exercises, ensuring continuous feedback and adherence. Methods: Randomized clinical trial. Intervention of 3 weekly strength training ses-sions for 20 weeks, patients in the experimental group used the AI application, while patients in the control group followed the conventional method, paper-based exercises with access to videos.

Conditions

Interventions

TypeNameDescription
OTHERTelerehabilitationEG performed using an artificial intelli-gence (AI) application called RehBody, which detects body segments, assists in cor-recting the technique and monitoring the exercise, number of sets and repetitions done, and the adherence percentage
OTHERExercise programCG participants followed the exercise program and trained at home with images and videos as support.

Timeline

Start date
2025-04-01
Primary completion
2025-08-15
Completion
2025-08-31
First posted
2025-03-11
Last updated
2025-09-19

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06871072. Inclusion in this directory is not an endorsement.